2. Academic Validation
  3. The Possible Connection of Two Dual Function Processes: The Relationship of Ferroptosis and the JNK Pathway

The Possible Connection of Two Dual Function Processes: The Relationship of Ferroptosis and the JNK Pathway

  • Int J Mol Sci. 2022 Sep 20;23(19):11004. doi: 10.3390/ijms231911004.
Dóra Varga 1 2,  Péter Hajdinák 1 2,  Kinga Makk-Merczel 1 2,  András Szarka 1 2
Affiliations

Affiliations

  • 1 Laboratory of Biochemistry and Molecular Biology, Department of Applied Biotechnology and Food Science, Budapest University of Technology and Economics, Szent Gellért tér 4, H-1111 Budapest, Hungary.
  • 2 Biotechnology Model Laboratory, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Szent Gellért tér 4, H-1111 Budapest, Hungary.
PMID: 36232313 DOI: 10.3390/ijms231911004
Abstract

Ferroptosis represents a typical process that has dual functions in cell fate decisions since the reduction and/or inhibition of Ferroptosis is desirable for the therapies of diseases such as neurological disorders, localized ischemia-reperfusion, kidney injury, and hematological diseases, while the enhanced Ferroptosis of Cancer cells may benefit patients with Cancer. The JNK pathway also has a real dual function in the fate of cells. Multiple factors suggest a potential link between the ferroptotic and JNK pathways; (i) both processes are ROS mediated; (ii) both can be inhibited by lipid peroxide scavengers; (iii) Ras mutations may play a role in the initiation of both pathways. We aimed to investigate the possible link between Ferroptosis and the JNK pathway. Interestingly, JNK Inhibitor co-treatment could enhance the Cancer cytotoxic effect of the Ferroptosis inducers in NRAS and KRAS mutation-harboring cells (HT-1080 and MIA PaCa-2). Since cancer's cytotoxic effect from the JNK inhibitors could only be suspended by the Ferroptosis inhibitors, and that sole JNK-inhibitor treatment did not affect cell viability, it seems that the JNK inhibitors "just" amplify the effect of the Ferroptosis inducers. This Cancer cell death amplifying effect of the JNK inhibitors could not be observed in other oxidative stress-driven cell deaths. Hence, it seems it is specific to Ferroptosis. Finally, our results suggest that GSH content/depletion could be an important candidate for switching the anti-cancer effect of JNK inhibitors.

Keywords

JNK pathway; cancer; cell death; ferroptosis; reactive oxygen species.

Figures
Products